The Barclays share price drops on results day, but is the stock a buy?

For income-hunting investors, does the 7.4% anticipated dividend yield justify ignoring the recent Barclays share price decline?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Man putting his card into an ATM machine while his son sits in a stroller beside him.

Image source: Getty Images

The Barclays (LSE: BARC) share price dropped on 24 October 2023 with the release of its third-quarter results.

In early trading on the day, the stock was down by around 6.5% near 135p. And that made it the biggest faller in the FTSE 100.

Dividend advances ahead

Chief executive CS Venkatakrishnan said the banking firm achieved a return on tangible equity of 11% in the period “against a mixed market backdrop”.

However, earnings look set to be lower for the year. And on top of that, the outlook statement might have done some damage to investor confidence. The directors are evaluating possible actions to help drive future returns. But those moves may lead to “material” additional costs in the fourth quarter.

Nevertheless, there’s no hint in the report of any proposed trimming of the shareholder dividend. And the company seems to be wedded to its progressive policy for shareholder payments.

I think that makes the stock worth consideration for dividend-hunting investors.

City analysts expect decent, double-digit percentage advances in the shareholder payment in 2023 and 2024. And set against those estimates, the anticipated yield for 2024 is running near 7.4%.

It’s never guaranteed that any company will make its estimates. But that level of yield is eye-catching and worthy of further research.

But there’s a problem – and it’s been going on for many years with Barclays. The big negative is the dreadful long-term performance of the share price.

Let’s be kind to the company and only consider the stock since the rebound after the banking crisis of 2007/08. 

Since bouncing up to around 350p by October 2009, there’s no denying the trend since then has been down.

And that’s a problem for income-hunters. There’s no point collecting a stream of dividends for years if the capital value of the investment erodes those gains.

The challenge of cyclicality

That’s why my personal strategy for dividend investments requires an underlying business to show at least modest annual gains for revenue, earnings and cash flow. That requirement can help to keep the share price buoyant and the dividends rising.

But Barclays fails this basic test. Banks are cyclical. And that tends to lead to a famine-or-feast performance from key financial indicators – including dividends.

A glance at the five-year financial record for Barclays shows the cyclicality in action. Some years show hefty declines for annual earnings, cash flow and dividends. And that’s the cyclicality playing out.

For me, that means Barclays is a poor candidate for a long-term buy-and-hold strategy. And that’s despite the huge yield the stock has now.

We never know for sure when the business will plunge into a downturn with a collapse in earnings, dividends, cash flow and the share price.

However, the stock does present opportunities for fleet-footed investors with a shorter holding timeframe. After all, cyclicality works in both directions. And advances for the stock can be rapid on the upswing.

But timing the purchase of an out-and-out cyclical like Barclays is notoriously difficult. So, for me, this one goes on the ‘too difficult’ pile right now and I’ll watch from the sidelines for the time being.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has recommended Barclays Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »